Vireo Health International, Inc. (VREOF): Price and Financial Metrics


Vireo Health International, Inc. (VREOF): $2.40

0.07 (+3.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

VREOF Stock Price Chart Interactive Chart >

Price chart for VREOF

VREOF Price/Volume Stats

Current price $2.40 52-week high $3.84
Prev. close $2.33 52-week low $0.47
Day low $2.35 Volume 289,500
Day high $2.52 Avg. volume 381,069
50-day MA $2.22 Dividend yield N/A
200-day MA $1.87 Market Cap N/A

Vireo Health International, Inc. (VREOF) Company Bio


Vireo Health International, Inc. operates as a cannabis company. The Company produces pharmaceutical-grade cannabis extracts and sells its products to company owned and third-party dispensaries.


VREOF Latest News Stream


Event/Time News Detail
Loading, please wait...

VREOF Latest Social Stream


Loading social stream, please wait...

View Full VREOF Social Stream

Latest VREOF News From Around the Web

Below are the latest news stories about Vireo Health International Inc that investors may wish to consider to help them evaluate VREOF as an investment opportunity.

Vireo Health announces name change to Goodness Growth Holdings; issues FY2022 outlook above consensus in conjunction with its 2021 Investor Day

Vireo Health ([[VREOF]] +5.2%) announces a series of corporate updates in conjunction with its 2021 Investor Day events; effective June 9, 2021 at market open, its subordinate voting shares will begin trading as Goodness Growth Holdings, under the ticker symbol "GDNS" on the Canadian Securities Exchange and on the OTCQX Market...

Seeking Alpha | June 8, 2021

Vireo Health Announces Name Change to Goodness Growth Holdings in Conjunction with 2021 Investor Day Events

Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), the leading physician-led, science-focused multi-state cannabis company, today announced a series of corporate updates in conjunction with its 2021 Investor Day events. In addition to unveiling its Horizon Strategy and outlook ranges for FY22 revenue and adjusted EBITDA performance, the Company also announced that effective June 9, 2021 at market open, its subordinate voting shares will begin trading as Goodne

Yahoo | June 8, 2021

Vireo Health to Host Virtual Investor Day Events on June 8th and June 9th

Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), the leading physician-led, science-focused multi-state cannabis company, today announced that it will host a series of online virtual events for the institutional and retail investment communities on Tuesday, June 8, 2021 and Wednesday, June 9, 2021.

Yahoo | May 19, 2021

Vireo Health International misses on revenue

Vireo Health International (VREOF): Q1 GAAP EPS of -$0.06.Revenue of $13.2M (+8.9% Y/Y) misses by $0.15M.Press Release...

Seeking Alpha | May 14, 2021

Vireo Health to Report First Quarter 2021 Results on May 14, 2021

Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO, OTCQX: VREOF), the leading physician-founded, science-focused multi-state cannabis company, today announced that it will report financial results for its first quarter ended March 31, 2021 on Friday, May 14, 2021 before the market opens.

Yahoo | May 4, 2021

Read More 'VREOF' Stories Here

VREOF Price Returns

1-mo N/A
3-mo N/A
6-mo -8.75%
1-year 137.62%
3-year N/A
5-year N/A
YTD 62.22%
2020 38.27%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7981 seconds.